Feride Frech

2.5k total citations · 1 hit paper
41 papers, 2.0k citations indexed

About

Feride Frech is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Feride Frech has authored 41 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Geriatrics and Gerontology. Recurrent topics in Feride Frech's work include Blood Pressure and Hypertension Studies (8 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Sleep and related disorders (6 papers). Feride Frech is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Sleep and related disorders (6 papers). Feride Frech collaborates with scholars based in United States, Switzerland and Japan. Feride Frech's co-authors include Kristijan H. Kahler, K. Arnold Chan, Susan E. Andrade, Victoria Barghout, Joshua J. Ofman, John B. Wong, C.F. Chiou, Kai D. Knight, Bonnie B. Dean and Daniel Aguilar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Feride Frech

39 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Methods for evaluation of medication adherence and persistence using automated databases

2006 886 citations Susan E. Andrade, Kristijan H. Kahler et al. Pharmacoepidemiology and Drug Safety profile →

Peers

Countries citing papers authored by Feride Frech

Since Specialization

Citations

This map shows the geographic impact of Feride Frech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feride Frech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feride Frech more than expected).

Fields of papers citing papers by Feride Frech

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feride Frech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feride Frech. The network helps show where Feride Frech may publish in the future.

Co-authorship network of co-authors of Feride Frech

This figure shows the co-authorship network connecting the top 25 collaborators of Feride Frech. A scholar is included among the top collaborators of Feride Frech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feride Frech. Feride Frech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Initial Real-World Evidence for Lecanemab in the United States 2025 ·Drugs & Aging ·Diana Brixner, (unknown), (unknown), Feride Frech, Michael Rosenbloom	0
2	Characterizing the Journey of Early Alzheimer’s Disease in Patients Initiating Lecanemab Treatment in the United States: A Real-World Evidence Study 2025 ·Neurology and Therapy ·Marwan N. Sabbagh, (unknown), (unknown), (unknown), François Laliberté, (unknown), (unknown), Feride Frech, Kavita V. Nair	0
3	Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States 2024 ·The Journal of Prevention of Alzheimer s Disease ·Feride Frech, Li Gui, (unknown), Yingying Ding, Soeren Mattke, (unknown), Aaron S. Rosenberg, (unknown), (unknown), Richard Batrla, Susan De Santi, Heather Hampel	2
4	The age-specific comorbidity burden of mild cognitive impairment: a US claims database study 2023 ·Alzheimer s Research & Therapy ·Gang Li, Nicola Toschi, Viswanath Devanarayan, Richard Batrla, (unknown), Min Cho, (unknown), Feride Frech, James E. Galvin, David Henley, Soeren Mattke, Susan De Santi, Harald Hampel	11
5	Benzodiazepine Usage, Healthcare Resource Utilization, and Costs Among Older Adults Treated with Common Insomnia Medications: A Retrospective Cohort Study 2023 ·ClinicoEconomics and Outcomes Research ·Emerson M. Wickwire, (unknown), (unknown), (unknown), Feride Frech	5
6	Economic burden of comorbid insomnia in 5 common medical disease subgroups 2023 ·Journal of Clinical Sleep Medicine ·Emerson M. Wickwire, (unknown), (unknown), (unknown), (unknown), Feride Frech	5
7	Patient-Reported Outcome Measures in Adult Patients Diagnosed with Epilepsy Being Treated with Perampanel 2022 ·SHILAP Revista de lepidopterología ·Brian D. Moseley, Shaloo Gupta, (unknown), Jonathan P. Wright, John Rowland, Victoria Barghout, Feride Frech, Craig Plauschinat	2
8	Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines 2022 ·BMC Geriatrics ·(unknown), (unknown), Feride Frech, Weiying Wang, Zheng Wu, Norman Atkins, Emerson M. Wickwire	27
9	Real-world hospitalization risk in patients with epilepsy treated with perampanel 2020 ·Epilepsy & Behavior ·Xuan Li, Feride Frech, Craig Plauschinat, Mugdha Gore	6
10	Budgetary Impact of Telotristat Ethyl, a Novel Treatment for Patients with Carcinoid Syndrome Diarrhea: A US Health Plan Perspective 2017 ·Clinical Therapeutics ·Vijay N. Joish, Feride Frech, Pablo Lapuerta	7
11	The Development of the Herpes Symptom Checklist and the Herpes Outbreak Impact Questionnaire 2008 ·Value in Health ·Lynda Doward, Stephen P. McKenna, David Meads, (unknown), Feride Frech	4
12	Methods for evaluation of medication adherence and persistence using automated databases breakdown → 2006 ·Pharmacoepidemiology and Drug Safety ·Susan E. Andrade, Kristijan H. Kahler, Feride Frech, K. Arnold Chan	886
13	Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: A budget impact analysis 2005 ·Clinical Therapeutics ·Dean G. Smith, Annamaria Cerulli, Feride Frech	20
14	International development of the Parents’ Index of Quality of Life in Atopic Dermatitis (PIQoL-AD) 2005 ·Quality of Life Research ·Stephen P. McKenna, Diane Whalley, (unknown), Ruud A.M. Erdman, Thomas Kohlmann, Mauro Niero, (unknown), Sharon A. Cook, B. Crickx, Feride Frech, D van Assche	67
15	Assessment of Drug Therapy Management and the Prevalence of Heart Failure in a Managed Care Population With Hypertension 2004 ·Journal of Managed Care Pharmacy ·James H. Jackson, Feride Frech, (unknown), (unknown), (unknown), (unknown)	7
16	A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD) 2004 ·British Journal of Dermatology ·D Whalley, S. P. McKenna, (unknown), Rudolph A. M. Erdman, Thomas Kohlmann, Mauro Niero, Stuart A. Cook, B. Crickx, Michael Herdman, Feride Frech, D van Assche	102
17	Irritable Bowel Syndrome, Health Care Use, and Costs: A U.S. Managed Care Perspective 2003 ·The American Journal of Gastroenterology ·George F. Longstreth, (unknown), Kai D. Knight, John B. Wong, C.F. Chiou, Victoria Barghout, Feride Frech, Joshua J. Ofman	210
18	Patient Adherence With Amlodipine, Lisinopril, or Valsartan Therapy in a Usual-Care Setting 2003 ·Journal of Managed Care Pharmacy ·(unknown), C. Kreilick, (unknown), (unknown), Feride Frech	77
19	Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome 2003 ·Current Medical Research and Opinion ·Bradley C. Martin, Rahul Ganguly, (unknown), Feride Frech, Victoria Barghout	25
20	A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma. 2002 ·PubMed ·Chris M Kozma, Victoria Barghout, Terra Slaton, Feride Frech, C. Eugene Reeder	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact